Cambridge-1 and the future of medicine

Robert Marcus
Nov 3, 2021

Related news

Sep 20
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Venture capitalists raise more than $100bn to target life sciences

Sep 15
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Federated learning for predicting clinical outcomes in patients with COVID-19

Feb 26
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Can tech for good be as profitable as plain old tech?

Sep 14
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

How AI simplifies data management for drug discovery

Nov 3
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AWS Snatches Growth-Rate Momentum from Microsoft, Cites Machine Learning

Nov 16
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Breakthrough science and the future of venture capital

Mar 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Gartner: 75% of VCs will use AI to make investment decisions by 2025

Nov 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Accenture (ACN) Announces Strategic Investment in Geneyx

Dec 28
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

EU Investor confidence rises to a near all-time high

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Intelligence Artificielle : l'UM6P signe un partenariat avec la start-up ALPHA10X

Feb 1
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus